June 14, 2024

1649-P: S-309309, a Novel MGAT2 Inhibitor, Enhances Intestinal Fatty Acid Beta Oxidation and Provides Metabolic Benefits in DIO Mice

Los puntos clave no están disponibles para este artículo en este momento.

Introduction Shionogi Shionogi Shionogi & Co., Ltd. H. Kato: None.

Me gusta

Guardar

Cite This Study

Yoshiki et al. (Fri,) studied this question.

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

Me gusta

Guardar